NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
Clinical Trials
17 trialsNCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT06341842 2024-04-02
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2 Recruiting
NCT05732051 2023-03-17
NARNIA
University Hospital, Akershus
Phase 2 Recruiting
NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT03186404 2022-02-08
SPARE-HF
University Health Network, Toronto
Phase 2 Unknown
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT02052102 2017-01-06
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
Phase 2 Unknown
NCT01120171 2015-10-07
Myocet Plus Endoxan for Older Patients With Breast Cancer
Hellenic Oncology Research Group
Phase 2 Terminated
NCT00377559 2015-10-06
MYOTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Completed
NCT00377780 2015-09-23
MYOHERTAX
Catharina Ziekenhuis Eindhoven
Phase 2 Terminated
NCT01301040 2013-08-30
Early Cardiac Toxicity of Adjuvant CT in Elderly BC.
Jules Bordet Institute
Phase 2 Terminated
NCT01095926 2013-06-28
Doxo
University Hospital Muenster
Phase 2 Completed